Could psychedelic drugs be a new treatment option for people with depression?
Study discussed the benefits of using psychedelics as an antidepressant option for those with depression.... Read More...
psychedelics
Mindfulness meditation enhances positive effects of psilocybin
Mindful meditation enhances the positive effects of a single dose of psilocybin by increasing empathy and reducing egocentricity.... Read More...
Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before
Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.... Read More...
‘Microdosers’ of psychedelics report improved mood, focus and creativity
Those who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics.... Read More...
Improved mood and focus reported by microdosers
Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.... Read More...
Boosting amino acid derivative may be a treatment for schizophrenia
Reduced levels of an amino acid called betaine is associated with schizophrenia pathology. Supplementing betaine levels improved cognitive and behavioral deficits in mouse models of schizophrenia. The amino acid also reduced oxidative stress at the molecular level.... Read More...
Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD
MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.... Read More...
Fast-acting psychedelic associated with improvements in depression/anxiety
5-MeO-DMT, a fast-acting synthetic psychedelic, shows promise for treating depression and anxiety. 80% of test subjects reported improvements in symptoms associated with depression and anxiety after taking the drug.... Read More...
Does Microdosing Improve Mood and Performance?
A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.... Read More...
Are Near Death Experiences Hallucinations?
Researchers consider the neurobiology of near death experiences.... Read More...
Microdoses of Psychedelics May Enhance Creative Problem Solving
A new study reports microdosing psychedelics may enhance creative problem solving without risk of hallucinations, or trips, associated with taking high doses of the substances.... Read More...
Potent Psychedelic DMT Mimics Near Death Experience in the Brain
Researchers report DMT, the psychoactive compound of ayahuasca, can mimic actual near death experiences in healthy subjects.... Read More...